Journey Medical Corporation (NASDAQ: DERM)
$5.5400
+0.3400 ( +7.16% ) 68.4K
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Market Data
Open
$5.5400
Previous close
$5.2000
Volume
68.4K
Market cap
$113.85M
Day range
$4.9400 - $5.6100
52 week range
$2.8500 - $8.1100
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 4 | Apr 29, 2024 |
10-k | Annual reports | 106 | Mar 29, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
8-k | 8K-related | 15 | Mar 21, 2024 |
4 | Insider transactions | 1 | Feb 23, 2024 |
8-k | 8K-related | 14 | Jan 02, 2024 |
4 | Insider transactions | 1 | Dec 08, 2023 |